# Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice

> **NCT02266771** · NA · COMPLETED · sponsor: **LifeBridge Health** · enrollment: 20 (actual)

## Conditions studied

- Wounds and Injuries

## Interventions

- **DEVICE:** NPWT with Instillation
- **DEVICE:** NPWT

## Key facts

- **NCT ID:** NCT02266771
- **Lead sponsor:** LifeBridge Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-09
- **Final completion:** 2017-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02266771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02266771, "Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02266771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*